804 Marked Efficacy of Difluoromethylornithine (DFMO) Plus Sulindac in Reducing Recurrent Colorectal Adenomas in Patients with Prior Adenomas: Results of a Randomized, Placebo-Controlled Double-Blind Trial

Authors :: Jayashri Kidao
C.G. Albers
John McCracken
Eugene W. Gerner
Daniel Pelot
Dennis J. Ahnen
Frank L. Meyskens
Michael J. Lawson
Ronald Griffin
Curt H. Hagedorn
Christine E. McLaren
Philip M. Carpenter
D.K. Turgeon
Sharon Fujikawa-Brooks
Source :: Gastroenterology. 134:A-113
Publication Year :: 2008
Publisher :: Elsevier BV, 2008.

Subjects :: Oncology
medicine.medical_specialty
Sulindac
Hepatology
business.industry
Gastroenterology
Placebo
Double blind
Internal medicine
Medicine
In patient
business
medicine.drug

Tools